Director-Affiliated Entity Files to Sell $13M in Liquidia Stock
LQDA has more than doubled off its 52-week low of $11.85 on elevated volume (3.1× avg).
Summary
A director-affiliated entity, Canaan VIII LP, plans to sell $13 million in Liquidia Corp stock, continuing a trend of significant insider sales.
Key Events · Ownership and Investor Activity · LQDA
-
Intent to Sell $13 Million in Stock
Canaan VIII LP, a director-affiliated entity, has filed a Form 144 to sell 200,000 shares of Liquidia Corp common stock, valued at approximately $13 million.
-
Continuation of Recent Sales
This proposed sale follows a previous disposition of 318,893 shares by Canaan VIII LP on May 11, 2026, which generated $15 million in gross proceeds.
-
Part of Broader Insider Distribution
The filing contributes to a pattern of significant insider selling at Liquidia Corp, with over $66 million in open-market sales by 11 active insiders in the last 90 days.
Analysis · LQDA · Life Sciences
Canaan VIII LP, an entity affiliated with a director, has filed a Form 144 indicating its intent to sell an additional $13 million worth of Liquidia Corp common stock. This follows a previous sale of $15 million by the same entity on May 11, 2026, and contributes to a broader pattern of significant insider distribution observed over the past 90 days. This ongoing selling pressure from a director-affiliated entity could be perceived negatively by the market.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LQDA was trading at $62.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.6B. The 52-week trading range was $11.85 to $66.24. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.